Literature DB >> 23223822

Empirical relationships among oliguria, creatinine, mortality, and renal replacement therapy in the critically ill.

Tal Mandelbaum1, Joon Lee, Daniel J Scott, Roger G Mark, Atul Malhotra, Michael D Howell, Daniel Talmor.   

Abstract

PURPOSE: The observation periods and thresholds of serum creatinine and urine output defined in the Acute Kidney Injury Network (AKIN) criteria were not empirically derived. By continuously varying creatinine/urine output thresholds as well as the observation period, we sought to investigate the empirical relationships among creatinine, oliguria, in-hospital mortality, and receipt of renal replacement therapy (RRT).
METHODS: Using a high-resolution database (Multiparameter Intelligent Monitoring in Intensive Care II), we extracted data from 17,227 critically ill patients with an in-hospital mortality rate of 10.9 %. The 14,526 patients had urine output measurements. Various combinations of creatinine/urine output thresholds and observation periods were investigated by building multivariate logistic regression models for in-hospital mortality and RRT predictions. For creatinine, both absolute and percentage increases were analyzed. To visualize the dependence of adjusted mortality and RRT rate on creatinine, the urine output, and the observation period, we generated contour plots.
RESULTS: Mortality risk was high when absolute creatinine increase was high regardless of the observation period, when percentage creatinine increase was high and the observation period was long, and when oliguria was sustained for a long period of time. Similar contour patterns emerged for RRT. The variability in predictive accuracy was small across different combinations of thresholds and observation periods.
CONCLUSIONS: The contour plots presented in this article complement the AKIN definition. A multi-center study should confirm the universal validity of the results presented in this article.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223822      PMCID: PMC3580030          DOI: 10.1007/s00134-012-2767-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  19 in total

Review 1.  Defining acute renal failure: physiological principles.

Authors:  Rinaldo Bellomo; John A Kellum; Claudio Ronco
Journal:  Intensive Care Med       Date:  2003-11-15       Impact factor: 17.440

2.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

3.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

4.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

Authors:  Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates
Journal:  J Am Soc Nephrol       Date:  2005-09-21       Impact factor: 10.121

Review 5.  Developing a consensus classification system for acute renal failure.

Authors:  John A Kellum; Nathan Levin; Catherine Bouman; Norbert Lameire
Journal:  Curr Opin Crit Care       Date:  2002-12       Impact factor: 3.687

6.  Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?

Authors:  Grace L Smith; Viola Vaccarino; Mikhail Kosiborod; Judith H Lichtman; Susan Cheng; Suzanne G Watnick; Harlan M Krumholz
Journal:  J Card Fail       Date:  2003-02       Impact factor: 5.712

7.  Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study.

Authors:  Andrea Lassnigg; Daniel Schmidlin; Mohamed Mouhieddine; Lucas M Bachmann; Wilfred Druml; Peter Bauer; Michael Hiesmayr
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

8.  North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE Criteria.

Authors:  Dinna N Cruz; Irene Bolgan; Mark A Perazella; Monica Bonello; Massimo de Cal; Valentina Corradi; Natalia Polanco; Catalina Ocampo; Federico Nalesso; Pasquale Piccinni; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2007-03-27       Impact factor: 8.237

9.  RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis.

Authors:  Eric A J Hoste; Gilles Clermont; Alexander Kersten; Ramesh Venkataraman; Derek C Angus; Dirk De Bacquer; John A Kellum
Journal:  Crit Care       Date:  2006-05-12       Impact factor: 9.097

Review 10.  Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

Authors:  Rinaldo Bellomo; Claudio Ronco; John A Kellum; Ravindra L Mehta; Paul Palevsky
Journal:  Crit Care       Date:  2004-05-24       Impact factor: 9.097

View more
  24 in total

1.  The urinary levels of prostanoid metabolites predict acute kidney injury in heterogeneous adult Japanese ICU patients: a prospective observational study.

Authors:  Haruyo Ujike-Omori; Yohei Maeshima; Masaru Kinomura; Katsuyuki Tanabe; Kiyoshi Mori; Hiroyuki Watatani; Norikazu Hinamoto; Hitoshi Sugiyama; Yoshiki Sakai; Hiroshi Morimatsu; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2015-02-11       Impact factor: 2.801

2.  Acute kidney injury: Urine output in AKI--the canary in the coal mine?

Authors:  Ravindra L Mehta
Journal:  Nat Rev Nephrol       Date:  2013-09-10       Impact factor: 28.314

3.  Biomarkers for AKI improve clinical practice: yes.

Authors:  Matthieu Legrand; Michael Darmon
Journal:  Intensive Care Med       Date:  2014-11-12       Impact factor: 17.440

4.  eResearch: the case of acute kidney injury.

Authors:  John A Kellum; Dilhari R DeAlmeida; Valerie J Watzlaf
Journal:  Intensive Care Med       Date:  2012-12-07       Impact factor: 17.440

Review 5.  Acute kidney injury-epidemiology, outcomes and economics.

Authors:  Oleksa Rewa; Sean M Bagshaw
Journal:  Nat Rev Nephrol       Date:  2014-01-21       Impact factor: 28.314

6.  Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria.

Authors:  Matthieu Legrand; Aurélien Jacquemod; Etienne Gayat; Corinne Collet; Veronique Giraudeaux; Jean-Marie Launay; Didier Payen
Journal:  Intensive Care Med       Date:  2014-12-03       Impact factor: 17.440

7.  Association between fluid balance and survival in critically ill patients.

Authors:  J Lee; E de Louw; M Niemi; R Nelson; R G Mark; L A Celi; K J Mukamal; J Danziger
Journal:  J Intern Med       Date:  2014-06-27       Impact factor: 8.989

8.  Severity of acute kidney injury and two-year outcomes in critically ill patients.

Authors:  Lior Fuchs; Joon Lee; Victor Novack; Yael Baumfeld; Daniel Scott; Leo Celi; Tal Mandelbaum; Michael Howell; Daniel Talmor
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

Review 9.  Acute kidney injury in 2013: Breaking barriers for biomarkers in AKI--progress at last.

Authors:  Dinna N Cruz; Ravindra L Mehta
Journal:  Nat Rev Nephrol       Date:  2013-12-24       Impact factor: 28.314

10.  Year in review in Intensive Care Medicine 2013: I. Acute kidney injury, ultrasound, hemodynamics, cardiac arrest, transfusion, neurocritical care, and nutrition.

Authors:  Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Jean-François Timsit; Elie Azoulay
Journal:  Intensive Care Med       Date:  2013-12-13       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.